文献速递关节外科创伤骨科

永久性活动型间隔器与二期翻修治疗慢性假体周围关节感染的倾向性评分匹配研究

A Permanent Articulating Spacer Versus Two-Stage Exchange for Chronic Periprosthetic Joint Infection: A Propensity Score-Matched Study.
PubMed 文献 · J Arthroplasty · 2023-01-30

回顾性倾向性评分匹配研究比较全膝关节置换术后慢性假体周围关节感染患者中,保留活动型间隔器(1.5期)与二期再植入的临床结局与费用。共116例患者纳入分析,1.5期组90天疼痛评分较低(2.9 vs 4.6,P=.0001),两组感染清除率均为79.3%,二期组至2年费用增加26,346美元(P=.0001)。

要点

  • 1.5期活动型间隔器组90天疼痛评分2.9,低于二期组的4.6(P=.0001)。
  • 两组感染清除率均为79.3%,再入院与再手术率无显著差异。
  • 二期翻修至2年费用较1.5期增加26,346美元(P=.0001)。

核心结论

  • 对于高风险候选者,活动型间隔器可保留膝关节功能、减少二期手术带来的并发症负担,并以与二期翻修相似的感染清除率降低费用。

研究设计与样本

  • 回顾性研究,纳入符合肌肉骨骼感染学会(MSIS)标准的全膝关节置换术后慢性假体周围关节感染患者,使用累积MSIS评分和合并症指数进行倾向性评分匹配,共116例患者纳入分析。
  • 1.5期队列为保留活动型间隔器(骨水泥钴铬股骨组件和全聚乙烯胫骨)的患者,2期队列为接受二期再植入手术的患者。

主要发现

  • 1.5期组90天疼痛视觉模拟评分低于2期组(2.9 vs 4.6,P=.0001)。
  • 两组再入院率和再手术率无显著差异,感染清除率两组均为79.3%。
  • 2期翻修至2年费用较1.5期增加26,346美元(P=.0001)。
  • 回归分析发现,同一微生物两次培养阳性降低再感染风险(比值比0.2,95%CI 0.04-0.8,P=.03)。

关键数值与推荐

  • 慢性假体周围关节感染定义采用肌肉骨骼感染学会(MSIS)标准。
  • 倾向性评分匹配使用累积MSIS评分和合并症指数。
  • 1.5期组间隔器为骨水泥钴铬股骨组件和全聚乙烯胫骨。
  • 结局指标包括疼痛视觉模拟评分、90天急诊就诊、90天再入院、非计划再手术、再感染及1年和2年费用。

临床怎么用

  • 作者认为,对于高风险候选者,活动型间隔器可保留膝关节功能、减少二期手术带来的并发症负担,并以与二期翻修相似的感染清除率降低费用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although 2-stage revision has been proposed as gold standard for periprosthetic joint infection treatment, limited evidence exists for the role of articulating spacers as definitive management. The purpose of this study was to compare clinical outcomes and costs associated with articulating spacers (1.5-stage) and a matched 2-stage cohort. METHODS: A retrospective review was performed for patients who had chronic periprosthetic joint infections after total knee arthroplasty defined by Musculoskeletal Infection Society criteria and were matched via propensity score matching using cumulative Musculoskeletal Infection Society scores and a comorbidity index. Patients who maintained an articulating spacer (cemented cobalt-chrome femoral component and all-poly tibia) were included in the 1.5-stage cohort. Patients who underwent a 2-stage reimplantation procedure were included in the 2-stage cohort. Outcomes included visual analog scale pain scores, 90-day emergency department visits, 90-day readmission, unplanned reoperation, reinfection, as well as cost at 1 and 2-year intervals. A total of 116 patients were included for analyses. RESULTS: The 90-day pain scores were lower in the 1.5-stage cohort compared to the 2-stage cohort (2.9 versus 4.6, P = .0001). There were no significant differences between readmission and reoperation rates. Infection clearance was equivalent at 79.3% for both groups. Two-stage exchange demonstrated an increased cost difference of $26,346 compared to 1.5-stage through 2 years (P = .0001). Regression analyses found 2 culture-positive results with the same organism decreased the risk for reinfection [odds ratio: 0.2, 95% confidence interval 0.04-0.8, P = .03]. CONCLUSION: For high-risk candidates, articulating spacers can preserve knee function, reduce morbidity from second-stage surgery, and lower the costs with similar rates of infection clearance as 2-stage exchange. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Belay ES, Wixted CM, Kim BI, et al. A Permanent Articulating Spacer Versus Two-Stage Exchange for Chronic Periprosthetic Joint Infection: A Propensity Score-Matched Study. J Arthroplasty. 2023. PMID: 36720418. doi:10.1016/j.arth.2023.01.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。